Results 151 to 160 of about 1,533 (199)
Theragnostics applications and challenges
Evangelista, Laura, Mansi, Luigi
openaire +3 more sources
Ribonoscopy and “Theragnostics”
The combined field of researches in drug therapy, diagnostics, and prognostics may be referred to as “theragnostics.” Some investigators have already coined the word “theranostics” to refer to the same but I prefer theragnostics over theranostics because the second stem in the latter word, “nostics,” has no etymological basis.
Sungchul Ji
openaire +2 more sources
Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics [PDF]
Molecular radiotherapy, or targeted radionuclide therapy, uses systemically administered drugs bearing a suitable radioactive isotope, typically a beta emitter.
Jennifer E Gains +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Theragnostics in prostate cancer
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022Prostate-specific membrane antigen (PSMA) is a molecular target for both imaging diagnostics and therapeutics, i.e., a theragnostics target. There has been a growing body of evidence supporting PSMA theragnostics approaches in the management of prostate cancer (PCa) for tailored precision medicine. Tumor characterization through PSMA-ligand PET imaging
Andrea, Farolfi +3 more
openaire +2 more sources
Theragnostics in Neuroendocrine Tumors
PET Clinics, 2021Several studies have demonstrated the effectiveness of somatostatin receptor (SSTR)-targeted imaging for diagnosis, staging, evaluating the possibility of treatment with cold somatostatin analogs, as well peptide receptor radionuclide therapy (PRRT), and evaluation of treatment response.
Margarida, Rodrigues +2 more
openaire +2 more sources
Theragnostic in neuroendocrine tumors
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022In the last few decades, the incidence and prevalence of neuroendocrine tumors has been increasing. The theragnostic approach, that allows the diagnosis and treatment of different neoplasms with the same ligand, is a typical nuclear medicine tool. Applied for years, is also pivotal in neuroendocrine tumors (NETs) where it has improved the diagnostic ...
Marini I. +12 more
openaire +2 more sources
Theragnostic radionuclides: a clinical perspective
The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 2022The concept of theragnostics goes back to the earliest days of nuclear medicine, with [123I/131I]iodide in thyroid disease and [123I/131I]MIBG in phaeochromocytoma being examples in long-term use. However, in recent years there has been a great expansion in the application of theragnostics, beginning with [68Ga/177Lu]-labelled somatostatin peptides for
Jacek, Koziorowski, James, Ballinger
openaire +2 more sources
Critical Care Medicine, 2009
Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results.
Frédéric, Pene +3 more
openaire +2 more sources
Theragnostics is a treatment strategy that combines therapeutics with diagnostics. It associates both a diagnostic test that identifies patients most likely to be helped or harmed by a new medication, and targeted drug therapy based on the test results.
Frédéric, Pene +3 more
openaire +2 more sources
Theragnostic nanomotors: Successes and upcoming challenges
WIREs Nanomedicine and Nanobiotechnology, 2021AbstractThe idea of “fantastic voyagers” carrying out medical tasks within the human body has existed as part of popular culture for many decades. The concept revolved around a miniaturized robot that can travel inside the human body and perform complicated functions such as surgery, navigation of otherwise inaccessible biological environments, and ...
Reshma Vasantha Ramachandran +3 more
openaire +2 more sources

